Intended Use

Software intended to aid in screening for Left Ventricular Ejection Fraction (LVEF) less than or equal to 40% in adults at risk for heart failure.

Technology

A software-based AI algorithm analyzing 10 seconds of 12-lead ECG voltage time series data. Delivered as a software module integrated with third-party medical software, providing a prediction of low LVEF to clinician systems.

Performance

The algorithm was trained on over 93,000 patients with paired ECG and echocardiogram measurements. Clinical validation on 16,000 patients from 4 US health systems showed sensitivity and specificity above 80% for detecting LVEF ≤ 40%, with subgroup analyses supporting consistency across demographics and ECG devices.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    9/5/2023

    23 days
  • 2

    FDA Approval

    9/28/2023

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.